Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease.

The Journal of Immunology : Official Journal of the American Association of Immunologists
Ashley ReynoldsHoward E Gendelman

Abstract

Nitrated alpha-synuclein (N-alpha-syn) immunization elicits adaptive immune responses to novel antigenic epitopes that exacerbate neuroinflammation and nigrostriatal degeneration in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of Parkinson's disease. We show that such neuroimmune degenerative activities, in significant measure, are Th17 cell-mediated, with CD4(+)CD25(+) regulatory T cell (Treg) dysfunction seen among populations of N-alpha-syn-induced T cells. In contrast, purified vasoactive intestinal peptide induced and natural Tregs reversed N-alpha-syn T cell nigrostriatal degeneration. Combinations of adoptively transferred N-alpha-syn and vasoactive intestinal peptide immunocytes or natural Tregs administered to MPTP mice attenuated microglial inflammatory responses and led to robust nigrostriatal protection. Taken together, these results demonstrate Treg control of N-alpha-syn-induced neurodestructive immunity and, as such, provide a sound rationale for future Parkinson's disease immunization strategies.

Associated Clinical Trials

Jun 20, 2013·Howard Gendelman, MD

References

Sep 1, 1995·Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration·V Jackson-LewisS Przedborski
Aug 28, 1997·Nature·M G SpillantiniM Goedert
Dec 22, 1999·The Journal of Immunology : Official Journal of the American Association of Immunologists·A M Thornton, E M Shevach
Jun 16, 2004·Proceedings of the National Academy of Sciences of the United States of America·Eric J BennerHoward E Gendelman
Aug 28, 2004·Proceedings of the National Academy of Sciences of the United States of America·Jonathan KipnisMichal Schwartz
Mar 26, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Wei ZhangJing Zhang
Oct 6, 2005·Journal of Leukocyte Biology·Mario DelgadoDoina Ganea
Jan 24, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Anne R GockeAmy E Lovett-Racke
Mar 17, 2007·Immunity·Arian LaurenceJohn J O'shea
Aug 7, 2007·Journal of Leukocyte Biology·Ashley D ReynoldsR Lee Mosley
Nov 13, 2007·Nature Immunology·Jason S StumhoferChristopher A Hunter
Nov 29, 2007·Proceedings of the National Academy of Sciences of the United States of America·Machteld M TiemessenLeonie S Taams
Dec 13, 2007·Neuroimmunomodulation·Javier LecetaYasmina Juarranz
Jul 24, 2008·PloS One·Rebecca BanerjeeHoward E Gendelman
Sep 24, 2008·Journal of Clinical Immunology·Amit AwasthiVijay K Kuchroo
Oct 24, 2008·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Dave MorganPaula Bickford
Nov 19, 2008·Proceedings of the National Academy of Sciences of the United States of America·Thomas KornMohamed Oukka
Mar 7, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jianuo LiuHoward E Gendelman
Mar 21, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ashley D ReynoldsHoward E Gendelman
May 13, 2009·Journal of Proteome Research·Ashley D ReynoldsHoward E Gendelman

❮ Previous
Next ❯

Citations

Jun 24, 2010·Journal of Neural Transmission·Li QianJau-Shyong Hong
Jul 13, 2011·Journal of Neural Transmission·Brinda Desai BradaricBill Hendey
Oct 12, 2012·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Jessica A Hutter SaundersHoward E Gendelman
Feb 9, 2012·Cold Spring Harbor Perspectives in Medicine·R Lee MosleyHoward E Gendelman
Jun 7, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Ashley S HarmsDavid G Standaert
Mar 16, 2011·Parkinson's Disease·Carina C Ferrari, Rodolfo Tarelli
Feb 19, 2011·Parkinson's Disease·Kemal Ugur TufekciKursad Genc
May 24, 2011·Parkinson's Disease·Anna R CartaEzio Carboni
Jun 14, 2013·Clinical & Developmental Immunology·Sandra L Bixler, Joseph J Mattapallil
Jul 23, 2014·BioMed Research International·Yinxia ChaoEng King Tan
Nov 28, 2013·Scientifica·Carlos Barcia
Jul 9, 2013·Molecular Neurobiology·Kazuhiro A FujitaRudi Balling
Nov 15, 2013·Clinical & Developmental Immunology·Kristen MarciniukScott Napper
Mar 4, 2011·Genes and Immunity·S M Metcalfe
Nov 5, 2014·The International Journal of Neuroscience·Sayinthen VivekananthamRele Ologunde
Nov 17, 2015·Expert Opinion on Therapeutic Targets·Emiliano Peña-AltamiraBarbara Monti
Nov 19, 2011·Expert Review of Neurotherapeutics·Jessica A L Hutter-SaundersHoward E Gendelman
Feb 14, 2016·Journal of Neurology·Marc Fakhoury
Feb 26, 2016·Brain : a Journal of Neurology·Cira DansokhoGuillaume Dorothée
Jan 21, 2011·Kidney International·Joshua D OoiA Richard Kitching
Apr 9, 2016·Journal of Neuroinflammation·Josefine R ChristiansenVanesa Sanchez-Guajardo
Feb 10, 2012·Immunopharmacology and Immunotoxicology·Farhad Jadidi-Niaragh, Abbas Mirshafiey
Mar 29, 2014·Human Vaccines & Immunotherapeutics·Marina Romero-RamosVanesa Sanchez-Guajardo
Apr 9, 2014·Frontiers in Immunology·Rodrigo PachecoMoncef Zouali
Aug 26, 2014·Frontiers in Oncology·Mohammad HaqueJianxun Song
Feb 24, 2017·Scandinavian Journal of Immunology·M von Euler Chelpin, T Vorup-Jensen
May 11, 2017·Journal of Neuroscience Research·Samuel S DuffyGila Moalem-Taylor
Nov 17, 2015·Current Opinion in Pharmacology·Katherine E Olson, Howard E Gendelman
Nov 14, 2016·Journal of the Neurological Sciences·Aline Silva de MirandaAntônio Lúcio Teixeira
Aug 18, 2012·Wiley Interdisciplinary Reviews. Systems Biology and Medicine·Feng He, Rudi Balling
Apr 14, 2015·Immunity, Inflammation and Disease·Adahir Labrador-GarridoCintia Roodveldt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.